Advertisement

Heart Failure Reviews

, Volume 24, Issue 1, pp 101–108 | Cite as

Autonomic nervous system in Takotsubo syndrome

  • Sonia Borodzicz
  • Katarzyna Czarzasta
  • Grzegorz Opolski
  • Agnieszka Cudnoch-JędrzejewskaEmail author
Article

Abstract

Takotsubo syndrome (TTS) is an acute and usually reversible heart failure syndrome with symptoms resembling acute myocardial infarction, however, without obstruction of coronary arteries. In the majority of cases, TTS is preceded by emotional or physical stress and the disease concerns mainly postmenopausal women. Although several hypotheses have been introduced, the pathogenesis of TTS is controversial and still remains to be determined. As reported in recent studies, the role of the autonomic nervous system (ANS) seems to be pivotal in the pathogenesis of TTS. Therefore, the aim of this article is to summarize and discuss the current knowledge of the pathogenesis of TTS with a special focus on the ANS.

Keywords

Takotsubo syndrome Pathophysiology Autonomic nervous system Sympathetic nervous system 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

The manuscript does not contain clinical studies or patient data.

References

  1. 1.
    Lyon AR, Bossone E, Schneider B, Sechtem U, Citro R, Underwood SR, Sheppard MN, Figtree GA, Parodi G, Akashi YJ, Ruschitzka F, Filippatos G, Mebazaa A, Omerovic E (2016) Current state of knowledge on Takotsubo syndrome: a position statement from the taskforce on Takotsubo syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 18(1):8–27.  https://doi.org/10.1002/ejhf.424 PubMedGoogle Scholar
  2. 2.
    Y-Hassan S, De Palma R (2017) Contemporary review on the pathogenesis of Takotsubo syndrome: the heart shedding tears: Norepinephrine churn and foam at the cardiac sympathetic nerve terminals. Int J Cardiol 228:528–536.  https://doi.org/10.1016/j.ijcard.2016.11.086 PubMedGoogle Scholar
  3. 3.
    Deshmukh A, Kumar G, Pant S, Rihal C, Murugiah K, Mehta JL (2012) Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J 164(1):66–71 e61.  https://doi.org/10.1016/j.ahj.2012.03.020 PubMedGoogle Scholar
  4. 4.
    Brinjikji W, El-Sayed AM, Salka S (2012) In-hospital mortality among patients with Takotsubo cardiomyopathy: a study of the National Inpatient Sample 2008 to 2009. Am Heart J 164(2):215–221.  https://doi.org/10.1016/j.ahj.2012.04.010 PubMedGoogle Scholar
  5. 5.
    Sato HTH, Umemura T, Dote K, Ishihara M (1990) Tako-tsubo-like left ventricular dysfunction due to multivessel coronary spasm. In: Kodama K, Haze K, Hori M (eds) Clinical aspect of myocardial injury: from ischemia to heart failure. Kagakuhyoronsha Publishing Co, Tokyo, Japan, pp 56–64Google Scholar
  6. 6.
    Dote K, Sato H, Tateishi H, Uchida T, Ishihara M (1991) Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol 21(2):203–214PubMedGoogle Scholar
  7. 7.
    Komamura K, Fukui M, Iwasaku T, Hirotani S, Masuyama T (2014) Takotsubo cardiomyopathy: pathophysiology, diagnosis and treatment. World J Cardiol 6(7):602–609.  https://doi.org/10.4330/wjc.v6.i7.602 PubMedPubMedCentralGoogle Scholar
  8. 8.
    Sharkey SW, Lesser JR, Maron MS, Maron BJ (2011) Why not just call it tako-tsubo cardiomyopathy. J Am Coll Cardiol 57(13):1496–1497PubMedGoogle Scholar
  9. 9.
    Haghi D, Athanasiadis A, Papavassiliu T, Suselbeck T, Fluechter S, Mahrholdt H, Borggrefe M, Sechtem U (2006) Right ventricular involvement in Takotsubo cardiomyopathy. Eur Heart J 27(20):2433–2439PubMedGoogle Scholar
  10. 10.
    Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Mitsuba N, Hata T, Nakama Y, Kisaka T, Kijima Y (2005) Takotsubo-like transient biventricular dysfunction with pressure gradients. Intern Med 44(7):727–732PubMedGoogle Scholar
  11. 11.
    Novak G, Kross K, Follmer K, Brofferio A, Shirani J (2007) Transient biventricular apical ballooning: a unique presentation of the “broken heart”. Clin Cardiol 30(7):355–358PubMedGoogle Scholar
  12. 12.
    Abdulla I, Kay S, Mussap C, Nelson G, Rasmussen H, Hansen P, Ward M (2006) Apical sparing in tako-tsubo cardiomyopathy. Intern Med J 36(7):414–418PubMedGoogle Scholar
  13. 13.
    Schneider B, Sechtem U (2016) Influence of age and gender in Takotsubo syndrome. Heart Fail Clin 12(4):521–530PubMedGoogle Scholar
  14. 14.
    Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, Seifert B, Hellermann J, Schwyzer M, Eisenhardt K, Jenewein J, Franke J, Katus HA, Burgdorf C, Schunkert H, Moeller C, Thiele H, Bauersachs J, Tschope C, Schultheiss HP, Laney CA, Rajan L, Michels G, Pfister R, Ukena C, Bohm M, Erbel R, Cuneo A, Kuck KH, Jacobshagen C, Hasenfuss G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Cuculi F, Banning A, Fischer TA, Vasankari T, Airaksinen KE, Fijalkowski M, Rynkiewicz A, Pawlak M, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Franz WM, Empen K, Felix SB, Delmas C, Lairez O, Erne P, Bax JJ, Ford I, Ruschitzka F, Prasad A, Luscher TF (2015) Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med 373(10):929–938.  https://doi.org/10.1056/NEJMoa1406761 PubMedGoogle Scholar
  15. 15.
    Ghadri JR, Sarcon A, Diekmann J, Bataiosu DR, Cammann VL, Jurisic S, Napp LC, Jaguszewski M, Scherff F, Brugger P, Jancke L, Seifert B, Bax JJ, Ruschitzka F, Luscher TF, Templin C, Inter TAKC-i (2016) Happy heart syndrome: role of positive emotional stress in takotsubo syndrome. Eur Heart J 37(37):2823–2829.  https://doi.org/10.1093/eurheartj/ehv757 PubMedPubMedCentralGoogle Scholar
  16. 16.
    Wittstein IS (2016) The sympathetic nervous system in the pathogenesis of Takotsubo syndrome. Heart Fail Clin 12(4):485–498PubMedGoogle Scholar
  17. 17.
    Wittstein IS (2012) Stress cardiomyopathy: a syndrome of catecholamine-mediated myocardial stunning? Cell Mol Neurobiol 32(5):847–857.  https://doi.org/10.1007/s10571-012-9804-8 PubMedGoogle Scholar
  18. 18.
    Nef HM, Mollmann H, Kostin S, Troidl C, Voss S, Weber M, Dill T, Rolf A, Brandt R, Hamm CW, Elsasser A (2007) Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J 28(20):2456–2464.  https://doi.org/10.1093/eurheartj/ehl570 PubMedGoogle Scholar
  19. 19.
    Aoki Y, Kodera S, Watanabe T, Miyauchi Y, Kanda J, Ooe K (2016) Autopsy findings in takotsubo cardiomyopathy with special reference to the autonomic nervous system. Int J Cardiol 203:236–237PubMedGoogle Scholar
  20. 20.
    Shams Y (2016) Clinical features and outcome of epinephrine-induced takotsubo syndrome: analysis of 33 published cases. Cardiovasc Revasc Med 17(7):450–455Google Scholar
  21. 21.
    Elikowski W, Małek-Elikowska M, Karoń J, Mrozińska M, Baszko A, Horbacka K (2017) Takotsubo cardiomyopathy after intravenous epinephrine administration following cardiac arrest provoked by pneumoperitoneum-a case report. Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego 42(250):165–169Google Scholar
  22. 22.
    Nassif J, Nahouli H, Khali A, Mikhael E, Gharzeddine W, Ghaziri G (2017) Epinephrine-induced Takotsubo cardiomyopathy during laparoscopic myomectomy: case report and review of the literature. J Minim Invasive Gynecol 24:1037–1039PubMedGoogle Scholar
  23. 23.
    Kajander OA, Virtanen MP, Sclarovsky S, Nikus KC (2013) Iatrogenic inverted takotsubo syndrome following intravenous adrenaline injections for an allergic reaction. Int J Cardiol 165(1):e3–e5PubMedGoogle Scholar
  24. 24.
    Collen J, Bimson W, Devine P (2008) A variant of Takotsubo cardiomyopathy: a rare complication in the electrophysiology lab. J Invasive Cardiol 20(11):E310–E313PubMedGoogle Scholar
  25. 25.
    Winogradow J, Geppert G, Reinhard W, Resch M, Radke P, Hengstenberg C (2011) Tako-tsubo cardiomyopathy after administration of intravenous epinephrine during an anaphylactic reaction. Int J Cardiol 147(2):309–311PubMedGoogle Scholar
  26. 26.
    Ghanim D, Adler Z, Qarawani D, Kusniec F, Amir O, Carasso S (2015) Takotsubo cardiomyopathy caused by epinephrine-treated bee sting anaphylaxis: a case report. J Med Case Rep 9(1):247PubMedPubMedCentralGoogle Scholar
  27. 27.
    Kido K, Guglin M (2017) Drug-induced Takotsubo cardiomyopathy. J Cardiovasc Pharmacol Ther 1074248417708618Google Scholar
  28. 28.
    Redfors B, Ali A, Shao Y, Lundgren J, Gan L-M, Omerovic E (2014) Different catecholamines induce different patterns of takotsubo-like cardiac dysfunction in an apparently afterload dependent manner. Int J Cardiol 174(2):330–336PubMedGoogle Scholar
  29. 29.
    Shao Y, Redfors B, Täng MS, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, Borén J, Omerovic E (2013) Novel rat model reveals important roles of β-adrenoreceptors in stress-induced cardiomyopathy. Int J Cardiol 168(3):1943–1950PubMedGoogle Scholar
  30. 30.
    Redfors B, Shao Y, Wikström J, Lyon AR, Oldfors A, Gan L-M, Omerovic E (2013) Contrast echocardiography reveals apparently normal coronary perfusion in a rat model of stress-induced (Takotsubo) cardiomyopathy. Eur Heart J Cardiovasc Imaging 15(2):152–157PubMedGoogle Scholar
  31. 31.
    Redfors B, Oras J, Shao Y, Seemann-Lodding H, Ricksten S-E, Omerovic E (2014) Cardioprotective effects of isoflurane in a rat model of stress-induced cardiomyopathy (takotsubo). Int J Cardiol 176(3):815–821PubMedGoogle Scholar
  32. 32.
    Sachdeva J, Dai W, Kloner RA (2014) Functional and histological assessment of an experimental model of Takotsubo’s cardiomyopathy. J Am Heart Assoc 3(3):e000921PubMedPubMedCentralGoogle Scholar
  33. 33.
    Kołodzińska A, Czarzasta K, Szczepankiewicz B, Główczyńska R, Fojt A, Ilczuk T, Budnik M, Krasuski K, Folta M, Cudnoch-Jędrzejewska A (2018) Toll-like receptor expression and apoptosis morphological patterns in female rat hearts with takotsubo syndrome induced by isoprenaline. Life Sci 199:112–121PubMedGoogle Scholar
  34. 34.
    Abraham J, Mudd JO, Kapur N, Klein K, Champion HC, Wittstein IS (2009) Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol 53(15):1320–1325PubMedGoogle Scholar
  35. 35.
    Randall WC, Szentivanyi M, Pace JB, Wechsler JS, Kaye MP (1968) Patterns of sympathetic nerve projections onto the canine heart. Circ Res 22(3):315–323PubMedGoogle Scholar
  36. 36.
    Kawano H, Okada R, Yano K (2003) Histological study on the distribution of autonomic nerves in the human heart. Heart Vessel 18(1):32–39Google Scholar
  37. 37.
    Kimura K, Ieda M, Fukuda K (2012) Development, maturation, and transdifferentiation of cardiac sympathetic nerves. Circ Res 110(2):325–336PubMedGoogle Scholar
  38. 38.
    Vincentz JW, Rubart M, Firulli AB (2012) Ontogeny of cardiac sympathetic innervation and its implications for cardiac disease. Pediatr Cardiol 33(6):923–928PubMedPubMedCentralGoogle Scholar
  39. 39.
    Zaroff JG, Rordorf GA, Ogilvy CS, Picard MH (2000) Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr 13(8):774–779PubMedGoogle Scholar
  40. 40.
    Vriz O, Minisini R, Citro R, Guerra V, Zito C, De Luca G, Pavan D, Pirisi M, Limongelli G, Bossone E (2011) Analysis of β1 and β2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy. Acta Cardiol 66(6):787–790PubMedGoogle Scholar
  41. 41.
    Mason DA, Moore JD, Green SA, Liggett SB (1999) A gain-of-function polymorphism in a G-protein coupling domain of the human β1-adrenergic receptor. J Biol Chem 274(18):12670–12674PubMedGoogle Scholar
  42. 42.
    Sandilands A, O’shaughnessy K, Brown M (2003) Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 β1-adrenoceptors versus Gly389 β1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 138(2):386–392PubMedPubMedCentralGoogle Scholar
  43. 43.
    Bruck H, Leineweber K, Temme T, Weber M, Heusch G, Philipp T, Brodde O-E (2005) The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity. J Am Coll Cardiol 46(11):2111–2115PubMedGoogle Scholar
  44. 44.
    Sharkey SW, Maron BJ, Nelson P, Parpart M, Maron MS, Bristow MR (2009) Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy. J Cardiol 53(1):53–57PubMedGoogle Scholar
  45. 45.
    Spinelli L, Trimarco V, Di Marino S, Marino M, Iaccarino G, Trimarco B (2010) L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome. Eur J Heart Fail 12(1):13–16PubMedGoogle Scholar
  46. 46.
    Figtree GA, Bagnall RD, Abdulla I, Buchholz S, Galougahi KK, Yan W, Tan T, Neil C, Horowitz JD, Semsarian C, Ward MR (2013) No association of G-protein-coupled receptor kinase 5 or beta-adrenergic receptor polymorphisms with Takotsubo cardiomyopathy in a large Australian cohort. Eur J Heart Fail 15(7):730–733.  https://doi.org/10.1093/eurjhf/hft040 PubMedGoogle Scholar
  47. 47.
    Klein C, Hiestand T, Ghadri J-R, Templin C, Jäncke L, Hänggi J (2017) Takotsubo syndrome–predictable from brain imaging data. Sci Rep 7:5434PubMedPubMedCentralGoogle Scholar
  48. 48.
    Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352(6):539–548PubMedGoogle Scholar
  49. 49.
    Kume T, Kawamoto T, Okura H, Toyota E, Neishi Y, Watanabe N, Hayashida A, Okahashi N, Yoshimura Y, Saito K (2008) Local release of catecholamines from the hearts of patients with tako-tsubo-like left ventricular dysfunction. Circ J 72(1):106–108PubMedGoogle Scholar
  50. 50.
    Morel O, Sauer F, Imperiale A, Cimarelli S, Blondet C, Jesel L, Trinh A, De Poli F, Ohlmann P, Constantinesco A (2009) Importance of inflammation and neurohumoral activation in Takotsubo cardiomyopathy. J Card Fail 15(3):206–213PubMedGoogle Scholar
  51. 51.
    Shams Y, Henareh L (2015) Plasma catecholamine levels in patients with takotsubo syndrome: implications for the pathogenesis of the disease. Int J Cardiol 181:35–38Google Scholar
  52. 52.
    Akashi Y, Barbaro G, Sakurai T, Nakazawa K, Miyake F (2007) Cardiac autonomic imbalance in patients with reversible ventricular dysfunction takotsubo cardiomyopathy. Journal of the Association of Physicians 100(6):335–343Google Scholar
  53. 53.
    Madhavan M, Borlaug BA, Lerman A, Rihal CS, Prasad A (2009) Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levels. Heart 95(17):1436–1441PubMedGoogle Scholar
  54. 54.
    Pinkham MI, Barrett CJ (2015) Estradiol alters the chemosensitive cardiac afferent reflex in female rats by augmenting sympathoinhibition and attenuating sympathoexcitation. Clin Exp Pharmacol Physiol 42(6):622–631PubMedGoogle Scholar
  55. 55.
    Saleh TM, Connell BJ (2000) 17β-Estradiol modulates baroreflex sensitivity and autonomic tone of female rats. J Auton Nerv Syst 80(3):148–161PubMedGoogle Scholar
  56. 56.
    Gautam S, Shankar N, Tandon OP, Goel N (2011) Comparison of cardiac autonomic functions among postmenopausal women with and without hormone replacement therapy, and premenopausal womenGoogle Scholar
  57. 57.
    Hart EC, Charkoudian N, Joyner MJ, Barnes JN, Curry TB, Casey DP (2013) Relationship between sympathetic nerve activity and aortic wave reflection characteristics in postmenopausal women. Menopause (New York, NY) 20(9):967Google Scholar
  58. 58.
    Perseguini NM, de Medeiros Takahashi AC, Milan JC, Dos Santos PR, Neves VFC, Borghi-Silva A, Silva E, Montano N, Porta A, Catai AM (2014) Effect of hormone replacement therapy on cardiac autonomic modulation. Clin Auton Res 24(2):63–70PubMedGoogle Scholar
  59. 59.
    Lavi S, Nevo O, Thaler I, Rosenfeld R, Dayan L, Hirshoren N, Gepstein L, Jacob G (2007) Effect of aging on the cardiovascular regulatory systems in healthy women. Am J Phys Regul Integr Comp Phys 292(2):R788–R793Google Scholar
  60. 60.
    Giavarini A, Chedid A, Bobrie G, Plouin P-F, Hagège A, Amar L (2013) Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma. Heart 99(19):1438–1444PubMedGoogle Scholar
  61. 61.
    Brugts JJ, van Gent M, Caliskan K, Kofflard MJ (2014) Repetitive stress-induced cardiomyopathy due to inverted Takotsubo in exaggerated sympathetic stimulation by pheochromocytoma. Eur Heart J Cardiovasc Imaging 16(1):113–113PubMedGoogle Scholar
  62. 62.
    Gagnon N, Mansour S, Bitton Y, Bourdeau I (2017) Takotsubo-like cardiomyopathy in a large cohort of patients with pheochromocytoma and paraganglioma. Endocr Pract 23:1178–1192PubMedGoogle Scholar
  63. 63.
    Coupez E, Eschalier R, Pereira B, Pierrard R, Souteyrand G, Clerfond G, Citron B, Lusson J-R, Mansencal N, Motreff P (2014) A single pathophysiological pathway in Takotsubo cardiomyopathy: catecholaminergic stress. Arch Cardiovasc Dis 107(4):245–252PubMedGoogle Scholar
  64. 64.
    Finsterer J, Wahbi K (2014) CNS disease triggering Takotsubo stress cardiomyopathy. Int J Cardiol 177(2):322–329PubMedGoogle Scholar
  65. 65.
    Porto I, Della Bona R, Leo A, Proietti R, Pieroni M, Caltagirone C, Spalletta G, Bolognese L, Cravello L (2013) Stress cardiomyopathy (tako-tsubo) triggered by nervous system diseases: a systematic review of the reported cases. Int J Cardiol 167(6):2441–2448PubMedGoogle Scholar
  66. 66.
    Khurana RK (2008) Takotsubo cardiomyopathy in a patient with postural tachycardia syndrome. Clin Auton Res 18(1):43–47PubMedGoogle Scholar
  67. 67.
    Harris ZM, Alonso A, Kennedy TP (2016) Adrenergic inhibition with dexmedetomidine to treat stress cardiomyopathy during alcohol withdrawal: a case report and literature review. Case reports in critical care 2016, 1, 9Google Scholar
  68. 68.
    Sarcon A, Ghadri J-R, Wong G, Lüscher TF, Templin C, Amsterdam E (2013) Takotsubo cardiomyopathy associated with opiate withdrawal. QJM: An International Journal of Medicine 107(4):301–302Google Scholar
  69. 69.
    Arora S, Alfayoumi F, Srinivasan V (2006) Transient left ventricular apical ballooning after cocaine use: is catecholamine cardiotoxicity the pathologic link? Mayo Clin Proc 81(6):829-32Google Scholar
  70. 70.
    Sharp RP, Welch EB (2011) Takotsubo cardiomyopathy as a complication of electroconvulsive therapy. Ann Pharmacother 45(12):1559–1565PubMedGoogle Scholar
  71. 71.
    Madias JE (2016) Low prevalence of diabetes mellitus in patients with Takotsubo syndrome: a plausible ‘protective’ effect with pathophysiologic connotations. Eur Heart J Acute Cardiovasc Care 5(2):164–170PubMedGoogle Scholar
  72. 72.
    Madias JE (2016) Details about diabetes mellitus in reported patients with Takotsubo syndrome, and its importance in unraveling the pathophysiology of the disease. Int J Cardiol 209:70–71PubMedGoogle Scholar
  73. 73.
    Madias JE (2016) An animal model of diabetic peripheral neuropathy and the pathophysiology of takotsubo syndrome: a proposal of an experiment. Int J Cardiol 222:882–884PubMedGoogle Scholar
  74. 74.
    Burgdorf C, Richardt D, Kurz T, Adler S, Nötzold A, Kraatz E, Sievers H, Richardt G (2003) Norepinephrine release is reduced in cardiac tissue of type 2 diabetic patients. Diabetologia 46(4):520–523PubMedGoogle Scholar
  75. 75.
    Stiermaier T, Moeller C, Oehler K, Desch S, Graf T, Eitel C, Vonthein R, Schuler G, Thiele H, Eitel I (2016) Long-term excess mortality in Takotsubo cardiomyopathy: predictors, causes and clinical consequences. Eur J Heart Fail 18(6):650–656PubMedGoogle Scholar
  76. 76.
    Shams Y (2015) The pathogenesis of reversible T-wave inversions or large upright peaked T-waves: sympathetic T-waves. Int J Cardiol 191:237–243Google Scholar
  77. 77.
    Shams Y (2015) RESPONSE: the electrocardiographic changes in mid-basal (inverted) Takotsubo syndrome. Ann Noninvasive Electrocardiol 6(20):614–614Google Scholar
  78. 78.
    Duran-Cambra A, Sutil-Vega M, Fiol M, Núñez-Gil I, Vila M, Sans-Roselló J, Cinca J, Sionis A (2015) Systematic review of the electrocardiographic changes in the takotsubo syndrome. Ann Noninvasive Electrocardiol 20(1):1–6PubMedGoogle Scholar
  79. 79.
    Abildskov J (1976) Adrenergic effects on the QT interval of the electrocardiogram. Am Heart J 92(2):210–216PubMedGoogle Scholar
  80. 80.
    Magnano AR, Talathoti N, Hallur R, Bloomfield DM, Garan H (2006) Sympathomimetic infusion and cardiac repolarization: the normative effects of epinephrine and isoproterenol in healthy subjects. J Cardiovasc Electrophysiol 17(9):983–989PubMedGoogle Scholar
  81. 81.
    Marra MP, Zorzi A, Corbetti F, De Lazzari M, Migliore F, Tona F, Tarantini G, Iliceto S, Corrado D (2013) Apicobasal gradient of left ventricular myocardial edema underlies transient T-wave inversion and QT interval prolongation (Wellens’ ECG pattern) in Tako-Tsubo cardiomyopathy. Heart Rhythm 10(1):70–77Google Scholar
  82. 82.
    Lee J-H, Uhm J-S, Shin DG, Joung B, Pak H-N, Ko Y-G, Hong G-R, Lee M-H (2016) Clinical significance of changes in the corrected QT interval in stress-induced cardiomyopathy. Korean J Intern Med 31(3):507–516PubMedPubMedCentralGoogle Scholar
  83. 83.
    Santoro F, Brunetti ND, Tarantino N, Romero J, Guastafierro F, Ferraretti A, Di Martino LF, Ieva R, Pellegrino PL, Di Biase M (2017) Dynamic changes of QTc interval and prognostic significance in takotsubo (stress) cardiomyopathy. Clin Cardiol 40:1116–1122PubMedGoogle Scholar
  84. 84.
    Waldenborg M, Soholat M, Kähäri A, Emilsson K, Fröbert O (2011) Multidisciplinary assessment of tako tsubo cardiomyopathy: a prospective case study. BMC Cardiovasc Disord 11(1):14PubMedPubMedCentralGoogle Scholar
  85. 85.
    Ortak J, Khattab K, Barantke M, Wiegand UK, Baensch D, Ince H, Nienaber CA, Bonnemeier H (2009) Evolution of cardiac autonomic nervous activity indices in patients presenting with transient left ventricular apical ballooning. Pacing Clin Electrophysiol 32(s1):S21–S25PubMedGoogle Scholar
  86. 86.
    Madias JE (2016) Do we need MIBG in the evaluation of patients with suspected Takotsubo syndrome? Diagnostic, prognostic, and pathophysiologic connotations. Int J Cardiol 203:783–784PubMedGoogle Scholar
  87. 87.
    Sverrisdóttir YB, Schultz T, Omerovic E, Elam M (2012) Sympathetic nerve activity in stress-induced cardiomyopathy. Clin Auton Res 22(6):259–264PubMedPubMedCentralGoogle Scholar
  88. 88.
    Vaccaro A, Despas F, Delmas C, Lairez O, Lambert E, Lambert G, Labrunee M, Guiraud T, Esler M, Galinier M (2014) Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy. PLoS One 9(3):e93278PubMedPubMedCentralGoogle Scholar
  89. 89.
    Norcliffe-Kaufmann L, Kaufmann H, Martinez J, Katz SD, Tully L, Reynolds HR (2016) Autonomic findings in Takotsubo cardiomyopathy. Am J Cardiol 117(2):206–213PubMedGoogle Scholar
  90. 90.
    Ali A, Redfors B, Omerovic E (2015) How baroreceptor dysfunction could predispose to the takotsubo syndrome. Int J Cardiol 182:105–106PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical ResearchMedical University of WarsawWarsawPoland
  2. 2.1st Chair and Department of CardiologyMedical University of WarsawWarsawPoland

Personalised recommendations